Reanalysis of the Multi‐Biomarker Disease Activity Score for Assessing Disease Activity in the Abatacept Versus Adalimumab Comparison in Biologic‐Naive Rheumatoid Arthritis Subjects with Background Methotrexate Study: Comment on the Article by Fleischmann et al - Curtis, Jeffrey R.; Wright, Grace C.; Strand, Vibeke; Davis, Charles S.; Hitraya, Elena; Sasso, Eric H. (Arthritis & rheumatology (Hoboken, N.J.), 2017)
Keywords: Abatacept; Adalimumab; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Biological Products; Biomarkers; Humans; Immunotherapy; Letters; Methotrexate; Monoclonal antibodies; Rheumatoid arthritis; TNF inhibitors